@article{dc2349ccedc843ecbf426d387e61b0fa,
title = "CD70 is a potential target biomarker in peripheral T-cell lymphomas",
keywords = "biomarker, CART, CD27, CD70, peripheral T-cell Lymphoma",
author = "Marques-Piubelli, {Mario L.} and Jason Sagert and Pham, {Minh Thu} and Matthias Will and Dan Henderson and Kimberly Tipton and Swaminathan Iyer and Wei Lu and Khan, {Khaja B.} and Leticia Hamana and Chapman, {Jennifer R.} and Beenu Thakral and Jie Xu and Miranda, {Roberto N.} and Kristofer Jennings and Solis, {Luisa M.} and Francisco Vega",
note = "Funding Information: F.V. receives research funding from CRISPR Therapeutics and Geron Corporation and received in the last 3 years honoraria from i3Health, Elsevier, America Registry of Pathology, Congressionally Directed Medical Research Program, and the Society of Haematology Oncology. S.P.I receives research funding from CRISPR, Seagen, Merck, Acrotech, Ono, Affimed, Rhizen, and Astra Zeneca. J.S., M.T.P, M.W., and K.T. are employees with equity interest in CRISPR Therapeutics. The remaining authors have no disclosures. Funding Information: This study was supported by the Translational Molecular Pathology‐Immunoprofiling Laboratory (TMP‐IL) at the Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center. ",
year = "2022",
month = aug,
doi = "10.1111/his.14670",
language = "English (US)",
volume = "81",
pages = "272--275",
journal = "Histopathology",
issn = "0309-0167",
publisher = "Wiley-Blackwell",
number = "2",
}